LON:SCLP Scancell (SCLP) Share Price, News & Analysis GBX 10.25 +0.10 (+0.99%) As of 08/22/2025 12:19 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Scancell Stock (LON:SCLP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Scancell alerts:Sign Up Key Stats Today's Range 9.93▼ 10.5050-Day Range 9.13▼ 11.6052-Week Range 7.26▼ 18.50Volume302,620 shsAverage Volume939,309 shsMarket Capitalization£106.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs. Our advanced therapeutic vaccine programmes, SCOPE and ModiFY, have shown promising efficacy in Phase 2 trials, demonstrating long-term survival in metastatic melanoma and a broad range of solid tumours. Read More Receive SCLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter. Email Address SCLP Stock News HeadlinesScancell Holdings plc (LON:SCLP) Insider Purchases £11,245.96 in StockAugust 9, 2025 | insidertrades.comMartin Diggle Buys 4,400,000 Shares of Scancell Holdings plc (LON:SCLP) StockAugust 5, 2025 | insidertrades.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.August 23 at 2:00 AM | The Oxford Club (Ad)Scancell Holdings Sees Significant Share Acquisition by Vulpes Testudo FundAugust 4, 2025 | tipranks.comScancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+July 23, 2025 | tmcnet.comScancell Hldgs Plc (SCLP)February 21, 2025 | uk.investing.comScancell Holdings Grants Share Options to Executive DirectorsFebruary 20, 2025 | tipranks.comWith 42% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interestJanuary 19, 2025 | finance.yahoo.comSee More Headlines SCLP Stock Analysis - Frequently Asked Questions How have SCLP shares performed this year? Scancell's stock was trading at GBX 10.85 at the beginning of the year. Since then, SCLP stock has decreased by 5.5% and is now trading at GBX 10.25. How were Scancell's earnings last quarter? Scancell Holdings plc (LON:SCLP) posted its earnings results on Thursday, January, 30th. The company reported ($1.35) EPS for the quarter. How do I buy shares of Scancell? Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Scancell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scancell investors own include KAZ Minerals (KAZ), Petropavlovsk (POG), Standard Chartered (STAN), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO) and Empyrean Energy (EME). Company Calendar Last Earnings1/30/2025Today8/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SCLP CIKN/A Webwww.scancell.co.uk Phone+44-115-8231863FaxN/AEmployees51Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.75 million Net MarginsN/A Pretax MarginN/A Return on Equity98.74% Return on Assets-45.28% Debt Debt-to-Equity Ratio-566.79 Current Ratio3.42 Quick Ratio13.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 1.30 per share Price / Cash Flow7.86 Book ValueGBX (0.39) per share Price / Book-26.30Miscellaneous Outstanding Shares1,035,724,932Free FloatN/AMarket Cap£106.16 million OptionableNot Optionable Beta0.35 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:SCLP) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scancell Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Scancell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.